Manufacturers and contract development and manufacturing organizations are developing processes and facilities to meet growing specialty API demand. For decades, APIs, the foundation of the ...

New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2023" - https ...

New York, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2021: COVID ...

As quality issues have led to drug shortages, Donald Ashley, director of FDA’s Office of Compliance, raised several major concerns on Tuesday with the active pharmaceutical ingredient (API) industry, ...

Eight months after convincing five companies to pay fines to settle antitrust claims, the European Commission has zeroed in on another firm, active pharmaceutical ingredients (API) manufacturer Alchem ...

In his latest article, Ames Gross explores the opportunities for pharma in China's API market. The active pharmaceutical ingredient (API) market in Asia is worth $32.5 billion, and it is growing ...

The US Food and Drug Administration (FDA) on Tuesday released a warning letter sent 27 June to China-based Zhuhai United Laboratories Co. for significant deviations from CGMP for active pharmaceutical ...

The active pharmaceutical ingredient (API) industry in India is on a significant growth path over the last few years. With the increasing demand for generic drugs, the scope for API manufacturing in ...

Indian API (Active Pharmaceutical Ingredient) manufacturers have remained in focus ever since the start of the pandemic. China's supply disruption earlier and rising API prices thereafter have ...

The agency issued a warning letter to Canadian API manufacturer, Les Produits Chimiques B.G.R, citing cGMP violations at its API facility in Pointe-Claire, Quebec. On July 24, 2018, FDA issued a ...